Instrument Inactif

Cours KV Pharmaceutical Co. CL 'B' NYSE

Actions

Cours en clôture NYSE Autres places de cotation
- ^USD	-

16/09/13	KV Pharmaceutical Co. CL 'B' : KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization
24/01/13	KV Pharmaceutical Co. CL 'B' : Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%) for Prescribing
28/12/12	KV Pharmaceutical Co. CL 'B' : K-V Pharmaceutical Receives Court Approval of Hologic Settlement
13/12/12	KV Pharmaceutical Co. CL 'B' : K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization

Employés

Secteur